Google
BNBX Stock Price & Analysis — Applied Dna Sciences, Inc. (Financial Services >> Asset Management)
BNBX FAQ
What is BNBX's ROE?
Applied Dna Sciences, Inc. reports a Return on Equity (ROE) of -275.69%.
What is BNBX's dividend yield?
Applied Dna Sciences, Inc. offers a dividend yield of 0.00%.
What is BNBX's Quality Score?
Our AI rates BNBX's overall financial quality at 15 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy BNBX?
Our AI Timing Score for BNBX is 0 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does BNBX belong to?
Applied Dna Sciences, Inc. is classified under the Financial Services >> Asset Management sector on the NASDAQ exchange
BNBX AI Analysis Summary
Our AI summary for BNBX: Applied Dna Sciences, Inc. (NASDAQ), Financial Services >> Asset Management sector. The stock currently trades at a P/E of 0.00, ROE of -275.69%, a dividend yield of 0.00%. Its financial Quality Score stands at 15/100 — fundamentals below the market average. The AI Timing Score is 0/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 0.11
Price
-0.00
(-1.87%)
Day Change
|
|
|---|
BNBX, the overall quality is not good ( Quality = 15) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
Negative growth of ROE in the last year.
Historical ROA is relatively low.
Historical ROA is relatively low.
Growth of ROA was below our criteria in the last year.
Net profit margin is relatively low.
Net profit margin is relatively low.
Historical net profit margin is relatively low.
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not good , and ability to make profit is ok , ...
| Quality Factors |
|
48% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 0.11 |
| PBV / Sector |
0.07 / 1.67
GREAT
|
| Earning Per Share | -4.79 |
| PE / Sector |
N/A / 13.89
|
| PEG or PE/Growth / Sector |
N/A / 0.03
|
| Average 1M Daily Value |
0.05 M
GREAT
|
| Average 1W Daily Value |
1151.693620000000
|
| Timing Factors |
|
57% |
| Financial Health |
|
45% |
| Ability to Make Profit |
|
64% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-08-06 07:59:43 |
| Symbol | BNBX |
| Name | APPLIED DNA SCIENCES, INC. |
| Sector | Financial Services >> Asset Management |
| Market | NASDAQ |
| Listed Shares | 7.20 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 0.79 / 7,445.49 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 50 Health Sciences Drive, Stony Brook, NY, United States, 11790
Phone: 631 240 8800
Website: https://www.bnbx.io
Description: BNB Plus Corp. provides digital asset treasury services. The company offers real-time data tracking of treasury performance and market indicators. The company, through its subsidiaries, also develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in the Americas, Europe, Asia, and internationally. The company engages in the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and nucleic acid production solutions for the biopharmaceutical and diagnostics industries, including LineaDNA, LineaRNAP, and LineaIVT, as well as the development and sale of a proprietary RNAP for use in the production of mRNA therapeutics. BNB Plus Corp. was formerly known as Applied DNA Sciences, Inc. and changed its name to BNB Plus Corp. in November 2025. The company was founded in 1983 and is based in Stony Brook, New York.
ME vs SECTOR Financial Services >> Asset Management
Click a bubble to view stock details · Bubble size represents market capitalization share
